최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.20 no.2, 2002년, pp.130 - 138
정웅기 (전남대학교 의과대학 치료방사선과학교실) , 오봉렬 (전남대학교 의과대학 비뇨기과학교실) , 안성자 (전남대학교 의과대학 치료방사선과학교실) , 나병식 (전남대학교 의과대학 치료방사선과학교실) , 권동득 (전남대학교 의과대학 비뇨기과학교실) , 박광성 (전남대학교 의과대학 비뇨기과학교실) , 류수방 (전남대학교 의과대학 비뇨기과학교실) , 박양일 (전남대학교 의과대학 비뇨기과학교실)
Purpose : This study analyzed the prognostic factors affecting the survival rate and evaluated the role of radiation therapy in muscle-invading bladder cancer. Materials and Methods : Twenty eight patients with bladder cancer who completed planned definitive radiotherapy in the Departments of Therap...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Pollack A, Zagars G and Swanson D. Muscle-invasive bladder cancer treated with external bearn radiotherapy: Prognostic factors. Int J Radiat Oncol Biol Phys 1994;30:267-277
Gospodarowicz MK, Hawkins MV, Rawling GA, et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 1989;142:1448-1454
Mameghan H, Fisher R, Mameghan J, et al. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinorna of the bladder. Int J Radiat Oncol Biol Phys 1995;31:247-254
Arias F, Dominguez MA, Martinez E, et al. Chernotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 2000;47:373-378
American Joint Committee on Cancer. Manual for staging of cancer. 5th ed. Philadelphia, New York; Lippincott Co, 1997:41-46
Kaplan EL and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
Cox DR. Regression models and life tables. J R Statis Soc B 1972;34:187-220
Jenkins BJ, Blandy JP, Caulfield MJ, et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive bladder cancer. Br J Urol 1988;62:343-346
DeNeve W, Lybeert ML, Goor C, et al. Radiotherapy for T2 and T3 carcinoma of the bladder : The influence of overall treatment time. Radiat Oncol 1995;36:183-188
Koiso K, Shipley W, Keuppens F, et al. The status of bladder preserving therapeutic strategies in the management of patients with muscle invasive bladder cancer. Int J Urol 1995;2(Suppl 2):49-57
Maciejewski B and Majewski S. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163-170
Dubben HH. Local control. $TCD_50$ , and dose timeprescription habits in radiotherapy of head and neck tumors. Radioth Oncol 1994;32:197-200
Van Putten WLJ, Van der Sangen MJC, Hoekstra CJM and Levendag PC. Dose fractionation and overall treatment time in radiation therapy : The effects on local control for cancer of the larynx. Radioth Oncol 1994;30:97-108
Withers HR, Peters LJ, Taylor JMG, et al. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995;33:549-562
Saunders MI, Dlsche S, Barret A, Parmar MK, Harvey A and Gibson D. Randomized multicenter trial of CHART versus conventional radiotherapy in head and neck and nonsmall cell cancer: A interim report. Br J Cancer 1996;73:1455-1462
Horiot JC, Bontemps P, Van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers : results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-121
Moonen L, Voet HVD, De Nus R, Horenblas S, Hart AAM and Bartelink H. Muscle invasive bladder cancer treated with external beam radiation: Influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 1998;42:525-530
Morisson R. The results of treatment of cancer of the bladder-a clinical contribution. Clin Radiol 1975;26:67-75
Jacobsen AB, Lunde S, Ous S, et al. T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cvtometric DNA ploidy values. Int J Rad Oncol Biol Phys 1989;17:923-929
Turner S, Swindell R, Bowl N, et al. Bladder movement during radiation therapy for bladder cancer: Implication for treatment planning. Int J Radiat Oncol Biol Phys 1994;30:199-200
Marks LB and Shipley WU. Techniques for external beam irradiation of patients with invasive carcinoma of the urinary bladder. In : Levitt, S. H., ed. Technologic basis of radiotherapy : Practical clinical applications, 2nd ed. Philadelphia : Lee & Febiger; 1992:335-341
Sur RK, clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder cancer. Clin Oncol 1993;5:30-33
Cole D, Durrant K, Robert J, et al. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol 1992;65:792-798
Shipley WU, Prout GR Jr , Einstein AB, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987;258:931-935
Scher HI, Herr HW, Sternberg C, et al. Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the MVAC regimen. Br J Urol 1989;64:250-256
Sauer R, Dunst J, Altendorf-Hofmann A, et al. Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 1990;19:687-691
Begg A. Cisplatin and radiation: Interaction probabilities and other therapeutic possibilities. Int J Radiat Oncol Biol Phys 1990;19:1183-1189
Flentje M, Eble M and Haner U. Additive effects of cisplatin and radiation in human tumor cells under oxic conditions. Radiother Oncol 1992;24:60-63
Mothersill C, Seymour CB, Cusak A, O'Brien A, Butler M. The effect of radiation and cytotoxic platinum compounds on the growth of normal and tumor bladder explant cultures. Acta Oncol 1990;29:179-184
Tester W, Porter A, Asbell S, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 1993;25:783-790
Dunst J, Sauer R, Schott KM, Kuhn R, Wittekind C and Altendorf-Hofman A. Organ-sparing treatment of advanced A. Organ- sparing treatment of advanced bladder cancer. A 10-year experience. Int J Radiat Oncol Biol Phys 1994;30:261-266
Sauer R, Birkenhake S, Khun R, Wittekind C, Schortt KM and Martus P. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998;40:121-127
Tester W, Caplan R, Heaney J, et al. Neoadjuvant combined program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II trial 8802. J Clin Oncol 1996;14:119-126
Shipley WU, Winter KA, Kaufman DS, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy. Initial results of Radiation Therapy Oncology Group. 89-03. J Clin Oncol 1998;16:3576-3583
※ AI-Helper는 부적절한 답변을 할 수 있습니다.